Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Safety Trial of Recombinant Surfactant Protein D to Prevent Neonatal Chronic Lung Disease

NCT05898633 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05898633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05898633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Safety Trial of Recombinant Surfactant Protein D to Prevent Neonatal Chronic Lung Disease
Lead sponsor
University College, London
Phase
Phase 1
Overall status
Completed
Start date
April 6, 2024
Completion date
December 31, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, chronic lung disease of prematurity, respiratory distress syndrome in premature infant